In addition, YAP/TAZ are activated in multiple human tumors including BC, hepatocellular carcinoma (HCC), prostate cancer, and lung cancer,68, 69, 70, 71 which is considered to be indicative of poor prognosis. Here, YAP1 is linked to hepatocellular carcinoma.